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590Objective: Open total arch procedures have been associated with significant morbidity and mortality in patients
with multiple comorbidities. Aortic arch debranching with endovascular graft placement, the hybrid arch proce-
dure, has emerged as a surgical option in this patient population. This study evaluates the outcomes of a contem-
porary comparative series from one institution of open total arch and hybrid arch procedures for extensive aortic
arch pathology.
Methods: From July 2000 to March 2009, 1196 open arch procedures were performed, including 45 elective and
7 emergency open total arch procedures. From 2005 to 2009, 64 hybrid arch procedures were performed: 37 emer-
gency type A dissections and 27 elective open arch debranchings. Hemiarch procedures were excluded.
Results: The hybrid arch cohort was significantly older (P ¼ .008) and had greater predominance of athero-
sclerotic pathophysiology (P< .001). The incidence of permanent cerebral neurologic deficit was similar at
4% (1/27) for the hybrid arch cohort and 9% (4/45) for the open aortic arch cohort. In-hospital mortality
was similar at 11% (3/27) for the hybrid arch cohort and 16% (7/45) for the open aortic arch cohort. However,
in the open arch group, there was a significant difference in mortality between patients aged less than 75 years
at 9% (3/34) and patients aged more than 75 years at 36% (4/11) (P ¼ .05).
Conclusions: Hybrid arch procedures provide a safe alternative to open repair. This study suggests the hybrid
arch approach has a lower mortality for high-risk patients aged more than 75 years. This extends the indication
for the hybrid arch approach in patients with complex aortic arch pathology previously considered prohibitively
high risk for conventional open total arch repair. (J Thorac Cardiovasc Surg 2010;140:590-7)Aortic arch replacement for extensive andcomplex archpathol-
ogy is technically challenging. Open total arch and total arch
plus descending aortic procedures can be accomplished elec-
tively with complex circulatory management and adjunct cere-
bral protection. However, these procedures, especially when
staged, have been associated with significant, sometimes pro-
hibitivemorbidity andmortality for thosepatientswithmultiple
comorbidities.1-6 Thoracic endovascular repair has become
recognized as a treatment alternative for uncomplicated aortic
pathology of the descending thoracic aorta with acceptable
midterm morbidity and mortality, and endovascular repair
recently has been advocated for complicated aortic
pathology, including type A dissections.1,2,7-10e Division of Cardiothoracic Surgery, Hospital of the University of
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The Journal of Thoracic and Cardiovascular SurgHybrid arch procedures that combine open brachioce-
phalic debranching with concomitant antegrade endovascu-
lar stent graft placement in the aortic arch in a single-stage
procedure have emerged as a treatment option for compli-
cated aortic arch pathology.1,7,9,10 This complex pathology
requires precise management and often modification of
landing zones (LZs) for endovascular placement. Studies
of brachiocephalic bypass procedures have demonstrated
the feasibility of these procedures with acceptable
mortality and neurologic outcomes.1,7,9,10
Appropriate selection of patients is essentialwhen consider-
ing an endovascular versus open aortic approach for complex
aortic arch pathology. This study evaluates the outcomes of
a contemporary comparative series from one institution of
open total arch, total arch plus descending aorta, and hybrid
surgical procedures for extensive aortic arch pathology.MATERIALS AND METHODS
Patient Characteristics
From July 2000 to March 2009, we performed 1196 open arch proce-
dures, of which 699 were elective hemiarch, 52 were total arch (45 elective
and 7 emergency), and 43 were arch and descending aorta (38 elective and
5 emergency) procedures. For patients with distal arch and proximal
descending procedures treated via a left thoracotomy, the most common
pathophysiology was chronic dissection (16 patients, 43.2%). The patientsery c September 2010
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
COPD ¼ chronic obstructive pulmonary disease
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermia and circulatory arrest
LZ ¼ landing zone
RCP ¼ retrograde cerebral perfusion
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them are currently being treated with thoracic endovascular stent grafting
at the Hospital of the University of Pennsylvania. This study excluded all
hemiarch procedures and included only elective procedures.
Open Total Arch Cohort
From 2000 to 2009, we performed 45 elective total arch procedures. The
mean age of patients was 62.8 13.5 years. The pathophysiology included
atherosclerotic in 26 patients (58%) and chronic dissection in 16 patients
(39%). Patients with atherosclerotic pathology had a mean maximum aortic
diameter of 7.3  1.5 cm (range, 5–11 cm), as measured from the outer
diameter of the aneurysm at its largest cross-sectional dimension.
Hybrid Arch Cohort
From 2005 to 2009, we performed 66 hybrid open endovascular proce-
dures via a sternotomy. Thirty-seven were emergencyDebakey I dissections
with a distal ‘‘stented elephant trunk.’’ Twenty-seven were ‘‘classic’’ elec-
tive open brachiocephalic debranching procedures with endovascular stent
graft placement (hybrid arch). Hybrid arch procedures included 17 patients
undergoing brachiocephalic debranching with endovascular stent graft
placement alone (type I), 2 patients with concomitant ascending arch re-
placement (type II), and 8 patients with concomitant ascending arch replace-
ment and extended stent graft coverage for atherosclerotic aneurysmal
involvement of the ascending, aortic arch, and descending aorta or
‘‘mega-aorta’’ pathologies (type III) (Figure 1). The mean age of patients
was 71.4 9.1 years (range, 52–84 years). The mean maximum size of ath-
erosclerotic aneurysm was 7.3  1.6 cm (range, 4.4–10 cm). Preoperative
patient characteristics are summarized in Table 1.
Preoperative Evaluation and Operative Technique
All patients were evaluated with multi-slice computed tomography
angiogram (M2S, West Lebanon, NH). Three-dimensional imaging was
obtained and used for preoperative evaluation and proper sizing of the
endovascular stent graft devices deployed in the arch.
Hybrid arch procedures were performed in a Hybrid Endosuite equipped
with a universal floor-mounted angiographic C-arm system.
Intraoperative transesophageal echocardiogramwas performed on all pa-
tients. Neuromonitoring with continuous electroencephalogramwas used in
all patients. All hybrid procedures also used somatosensory evoked poten-
tials monitoring.
Comparative statistical analysis between the hybrid and control groups
was conducted using SPSS version 15.0 (SPSS Inc, Chicago, Ill). The
Mann–Whitney test was used to assess differences between groups for nu-
meric variables. Fisher’s exact test was used to assess differences between
groups for categoric values.
Surgical Technique
Open total arch. Amedian sternotomy was performed in all patients.
Arterial cannulation was accomplished in the ascending aorta for all patients
undergoing open repair.The Journal of Thoracic and CaCardiopulmonary bypass (CPB) and deep hypothermia and circulatory
arrest (DHCA) were used in all open arch cases. Once core hypothermia
was reached, circulatory arrest was initiated with retrograde cerebral perfu-
sion (RCP). RCPwas usually performed for several minutes before selective
antegrade cerebral perfusion (ACP) via balloon-tipped cannulae, as previ-
ously described.8 Antegrade systemic circulation and rewarming were initi-
ated after completion of the distal anastomosis and de-airing of the aorta.
The supra-aortic vessels were reimplanted using a 4-branched graft.8 The
proximal takeoff of each arch vessel was detached, and end-to-end anasto-
mosis of the branched graft to the arch vessels was performed from the left
subclavian to the innominate artery with sequential clamping. De-airing
maneuvers were performed for each anastomosis before release of the
distal clamp.
Hybrid arch debranching. For type I saccular arch aneurysms, the
classic debranching procedure was performed using a 4-branched Dacron
graft anastomosed in an end-to-side fashion along the greater curve of the
ascending aorta, just distal to the sinotubular junction, to allow deployment
of the stent graft in the ascending aorta without compromise of the proximal
inflow anastomosis. The type IA (n ¼ 2) procedure was performed off by-
pass using a sidebiting clamp on the ascending aorta. If a limited amount of
aorta existed between the sinotubular junction and the ascending aorta, full
CPB with aortic crossclamping and cardiac arrest using standard cardiople-
gia was required (type IB, n ¼ 15). For patients with type II and III aortic
pathology, DHCAwas used. A segment of aorta just distal to the sinotubular
junction was identified for the proximal anastomosis and normalization of
the sinotubular junction performed using the 4-branch aortic graft. After
the patient achieved profound hypothermia and a flat electroencephalogram,
RCP was begun, and the aortic arch was opened. RCP was performed for
a brief period before selective ACP while the proximal aortic arch was pre-
pared for the type II (n¼ 2) or type IIIA (n¼ 4) and type IIIB (n¼ 4) hybrid
procedures. After complete dissection of the brachiocephalic vessels off the
aortic arch, selective ACP via balloon-tipped cannulae was initiated, and the
distal aortic arch anastomosis was completed. For all hybrid arch proce-
dures, the distal end-to-end anastomosis of the branched grafts to the arch
vessels was sequentially performed for the left subclavian, left common ca-
rotid, and innominate arteries. The proximal takeoff of each arch vessel was
detached using a stapling device. De-airing maneuvers were performed for
each anastomosis before release of the distal clamp. Stent grafts were de-
ployed antegrade during partial CPB in 21 of 27 patients (type IB, II,
IIIA). The Gore TAG endoprosthesis (WL Gore and Associates, Inc, New-
ark, DE) was used in 25 of 27 patients. One Talent device (Medtronic, Inc,
Minneapolis, MN) and 1 Cook TX2 device (Cook Medical Inc, Blooming-
ton, IN) was used in the remaining patients. Deployment of stent graft
devices was performed under fluoroscopy, and completion angiography
was performed in all cases. Deployment of the stent graft was successful
in 100% of cases. The average endovascular coverage length was 27.2 
8.6 cm for type I, 15 cm for type II, and 32.1  16.8 cm for type III.RESULTS
Patients undergoing hybrid procedures were significantly
older than patients undergoing open total arch repair (71.3
9.6 years vs 62.8  13.5 years, P ¼ .008). There was a sig-
nificant difference in aortic pathology between the 2 groups.
Ninety-three percent of patients undergoing a hybrid proce-
dure had atherosclerotic pathology, whereas 58% of patients
undergoing open total arch repair had atherosclerotic pathol-
ogy (P<.001). Saccular atherosclerotic pathology was more
prevalent in patients undergoing hybrid procedures (63% vs
18% in the open total arch group, P< .001) (Table 1).
Concomitant procedures were performed in both groups as
described in Table 2.rdiovascular Surgery c Volume 140, Number 3 591
FIGURE 1. Type I aortic pathology: For type I saccular arch aneurysm, the ‘‘classic’’ debranching procedure can be performed to bypass the cerebral ves-
sels. This procedure involves the end-to-side anastomoses of a 4-branched graft to the ascending aorta. This can be done off bypass using a sidebiting clamp on
the ascending aorta (IA). If a limited amount of aorta exists between the STJ and the ascending aorta, a full CPBwith crossclamp is required (IB). Type II aortic
arch pathology: This aortic pathology has no adequate suitable native proximal aorta but has a distal aorta for antegrade deployment of the endovascular graft.
However, this pathology requires reconstruction of LZ 0 with a 4-branch graft. Type III aortic arch pathology: For type III aortic arch pathology, or mega-
aorta, there is no adequate suitable native proximal ascending or descending aorta. The adequate suitable distal native aorta extends just proximal to the celiac
artery. Mega-aorta also requires reconstruction of LZ 0 with a branched graft. The remaining mega-aorta is addressed by intraoperative antegrade deployment
of the endovascular graft or by retrograde TEVAR during the same hospitalization. In some cases, an interval between the open debranching procedure and
completion of aneurysmal exclusion with further endovascular stent grafting is required (IIIB).
Acquired Cardiovascular Disease Milewski et al
A
C
DPrimary outcome data for overall in-hospital mortality
were not significantly different between the hybrid (11%)
and open total arch repair (16%) cohorts (P ¼ .739). The
overall incidence of transient neurologic complications
(cerebral and spinal cord) was not significantly different
between cohorts. Transient cerebral neurologic deficit oc-
curred in 5 patients (11%) in the open total arch cohort
and did not occur in patients undergoing hybrid arch proce-
dures. Transient, reversible, spinal cord ischemia occurred in
3 patients (11%) in the hybrid arch cohort and did not occur
in patients in the total arch cohort. There was no significant
difference in overall permanent neurologic complications
between the hybrid (13%) and open total arch (9%) cohorts
(P¼ 1.00). Permanent cerebral neurologic deficit, 2 embolic
and 2 intracerebral hemorrhage secondary to anticoagulation
therapy, occurred in 9% (2 deaths) in the total arch group
(P ¼ .644). A permanent cerebral neurologic deficit,
embolic in origin, occurred in 1 patient (4%, survived) in
the hybrid arch group. New postoperative paraplegia devel-
oped in 2 patients in the hybrid arch cohort (7%), resulting
in death before hospital discharge in both patients. The inci-
dence of new postoperative renal insufficiency and new
postoperative hemodialysis requirement was similar
between the 2 cohorts (Table 3).592 The Journal of Thoracic and Cardiovascular SurgWhen the hybrid and open total arch cohorts are stratified
by age, there are significant differences for in-hospital mor-
tality between groups. For the open hybrid group, there is no
significant difference between patients aged less than 75
years (2 deaths, 14%) and patients aged more than 75 years
(1 death, 8%). However, in the open total arch group, there
is a significant difference in mortality between patients aged
less than 75 years (9%) and patients aged more than 75 years
(36%) (P ¼ .05) (Table 3).
No endoleaks occurred in the hybrid arch group. Analysis
of long-term, all-cause mortality revealed no significant dif-
ference in survival between groups (Figure 2). The mean
length of follow-up was 13.3  2.6 months in the hybrid
arch cohort and 22.7  3.4 months in the open total arch
cohort.
DISCUSSION
The natural history of extensive pathologies of the aortic
arch carries grave survival outcomes. Despite recent ad-
vances in operative techniques, aortic arch replacement for
extensive and complex arch pathology remains a technical
challenge. The conventional approach for these complex
aortic repairs, direct open total arch or total arch plus de-
scending aortic replacement, can be accomplished electivelyery c September 2010
TABLE 1. Preoperative characteristics and comorbidities
Hybrid Open total arch
P valuesN 27 45
Age, y 71.3  9.6 62.8  13.5 .008
Gender (N male) 16 62% 24 52% .63
Prior CVA 3 12% 6 13% 1.00
Prior MI 5 19% 5 11% .26
CRF 3 12% 2 4% .344
Moderate/severe COPD 12 44% 5 11% .003
Smoker 18 67% 23 51% .077
Surgical history
Redo sternotomy 6 22% 15 33% .424
CABG 1 4% 5 11% .40
Root replace 0 4 9% .29
AVR/root 1 4% 3 7% 1.00
Asc aneurysm 0 0% 3 7% .287
Type A dissection repair 2 7% 9 20% .191
AAA 5 19% .006
Pathology
Atherosclerotic aneurysm 26 96% 26 58% <.001
Fusiform 9 33% 18 40% .623
Saccular 17 63% 8 18% <.001
High-grade/mobile
atheroma
13 48.1% 3 6.7% <.001
Chronic dissection 1 4% 16 36% <.001
Prior trauma 1 2%
Other 2 4%
AVR, Aortic valve replacement; AAA, abdominal aortic aneurysm; MI, myocardial in-
farction; CABG, coronary artery bypass grafting; CVA, cerebral vascular accident
(a documented history of stroke with loss of neurologic function with residual symp-
toms at least 72 h after onset); CRF, chronic renal failure (a documented history of re-
nal failure or a creatinine> 2.0); COPD, chronic obstructive pulmonary disease
(moderate, forced expiratory volume in 1 sec 50%–59% of predicted or receiving
chronic steroid therapy aimed at lung disease; severe, forced expiratory volume in
1 sec< 50% of predicted or room air PO2< 60, or PCO2> 50. A smoker is one
with a history of any form of tobacco use.
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bral protection. However, these procedures, especially when
staged, have been associated with significant, sometimes
prohibitive, morbidity and mortality for patients with multi-
ple comorbidities.1-6
Treatment of extensive aortic aneurysms requires innova-
tive surgical techniques and sophisticated patient selection.
Operative approaches for complex aortic pathologies have
undergone an evolution during the past 25 years; however,
the optimal surgical technique has not been definitively es-
tablished. The results of recent studies demonstrate that
open aortic arch replacement can be undertaken under
elective circumstances using contemporary techniques
with acceptable operative mortality and morbidity.6,11,12
This study analyzed a contemporary cohort of patients
who underwent elective open total aortic arch procedures us-
ing a branched graft, end-to-end arch vessel anastomotic
technique. These open total aortic arch procedures all used
a single standardized ACP and systemic circulatory protocol
throughout the time frame of the study. Although it is diffi-The Journal of Thoracic and Cacult to compare results from multiple institutions, our out-
comes are consistent with those of other series of open
aortic arch procedures.2-6,11,12 In our study, the results of
open aortic procedures revealed an overall mortality of
16% and a permanent cerebral neurologic deficit of 9%.
Other contemporary series report similar incidences of
mortality and permanent cerebral neurologic deficit.3-5,13
Although the results of open total arch repair have im-
proved, the morbidity and mortality associated with conven-
tional repair using CPB and DHCA are not insignificant. For
complicated aortic arch pathology in patients with multiple
prohibitive comorbidities, the hybrid procedure can be per-
formed with acceptable morbidity and mortality.1,7,9,10 This
complex aortic pathology requires precise management and
often modification of LZs for endovascular placement.1,7,10
In our series, for patients with type I saccular arch pathol-
ogy (n ¼ 17) with suitable native proximal and distal LZs,
the classic debranching procedure using a 4-branched graft
and antegrade deployment of the endovascular stent into
the native ascending aorta was performed either off (type
IA) or on (type IB) CPB. For type II arch pathology
(n ¼ 2) (unsuitable proximal LZ but suitable distal LZ), as-
cending aortic reconstruction of LZ 0 with the 4-branched
graft and endovascular stent deployment into a Dacron as-
cending aorta was performed. For patients with type III
‘‘mega-aorta’’ pathology (n ¼ 8) (unsuitable proximal LZ
and distal LZ), total arch replacement with simultaneous
‘‘frozen elephant trunk’’ endovascular stent deployment
(type IIIA, n ¼ 4) or early (generally<2 weeks) ‘‘stented
elephant trunk’’ (type IIIB, n¼ 4) was performed. The types
of hybrid procedures are illustrated in Figure 1.
Analysis of the 27 patients in the hybrid arch cohort
revealed that 93%had atherosclerotic aneurysms.Theoverall
mortalitywas 11% in this cohort of patients. This is consistent
with mortality seen in other hybrid series (0%–
15%).1,7,9,10,14 In our hybrid arch group, the incidence of
permanent cerebral neurologic deficit was 4%. Paraplegia
occurred in 2 patients (7%) and is consistent with other
hybrid series, which report a 0% to 10% incidence of
paraplegia.1,7,9,10,14 Both of these cases occurred early in
our series. One patient had standard endograft deployment
in the proximal descending aorta. The second patient had
extensive aneurysmal disease, including abdominal aortic
aneurysm requiring distal stent deployment to the celiac
artery. This extensive endovascular stent placement in
conjunction with abdominal aortic aneurysm has been
associated with spinal cord injury.14 Shimamura and col-
leagues,15 in a series of 126 elective and emergency hybrid
procedures, report actuarial survival estimates of 81.1%,
63.3%, and 53.7% at 1, 5, and 8 years after the procedure, re-
spectively. In our series the cumulative survival for the hybrid
procedure is 63% at 4 years (Figure 2).
A major advantage of the hybrid arch procedure is that
mega-aorta pathology can be repaired in patients in 1rdiovascular Surgery c Volume 140, Number 3 593
TABLE 2. Concomitant procedures and operative times
Hybrid Type 1 hybrid Type 2 hybrid Type 3 Hybrid Open total arch
N 27 17 2 8 45
Arch alone 13 48% 13 76% 8 18%
ArchþCABG 3 11% 3 18% 1 2%
ArchþAVR 1 4% 1 6% 1 2%
ArchþAsc 2 7% 2 100% 11 25%
ArchþAscþCABG 6 13%
ArchþAscþRoot 11 25%
ArchþAscþRootþCABG 3 6.7%
ArchþAscþRoot/AVRþDesc(Mega) 1 4% 1 13% 3 6.7%
ArchþAscþDesc(Mega) 7 26% 7 88% 1 2%
CPB time (m)* 220.8 61.5 282 55.7
Crossclamp time (m)* 83.2 62.1 192.5 65.1
CABG, Coronary artery bypass grafting; AVR, aortic valve replacement; CPB, cardiopulmonary bypass. *P value between groups< .001.
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generally less than 2 weeks. In patients with mega-aorta pa-
thology receiving a 2-stage ‘‘elephant trunk’’ repair, mortal-
ity incidences of up to 9.5% for the first stage, 8% to 11% in
the interval between stages, and 7.0% for the second stage
have been reported.2,3 For patients who do not return after
the first procedure, the incidence of mortality is reported
as high as 32% to 35%.2,3 For extensive aortic arch
pathologies, the results of a single-stage procedure using
a thoracosternotomy procedure include mortality incidence
of 6.6% to 14%, permanent neurologic deficit of 0% to
20%, and paraplegia in 1.4% to 14%.19,20 These results
suggest that an alternative treatment is needed for patients
with high morbidity due to extensive aortic pathology.
A recent series reported an improved outcome for theseTABLE 3. Outcomes
Hybrid Open total arch P
N ¼ 27 N ¼ 45 value
In-hospital mortality 3 11% 7 16% .739
Stroke 1 4% 4 9% .644
Transient neurologic deficit 0 5 11% .15
Permanent paraplegia 2 7% 0 .137
Reversed spinal
cord ischemia
3 11% 0 .049
renal failure 5 19% 5 11% .486
Renal failure
requiring new hemodialysis
3 11% 3 7% .665
Reoperation for bleeding 0 1 2% 1.00
Afibrillation 9 33% 13 29% .793
Mean hospital
stay (d)
20.1 15.9 17.5 16.2
Age stratification and mortality
In-hospital mortality
Hybrid arch Open total arch
<75 y 2 14% 3 9%
>75 y 1 8% 4 36%
594 The Journal of Thoracic and Cardiovascular Surgpatients using a ‘‘frozen’’ elephant trunk repair.21 We
have essentially abolished the use of an extended interval
‘‘staged elephant trunk’’ procedure at the Hospital of the
University of Pennsylvania. In our series, patients undergo-
ing staged repair of their mega-aorta in a conventional
manner (without hybrid arch and endovascular procedure)
had a mortality of 40%. Alternatively, when incorporating
a hybrid arch repair, and descending aortic endovascular
placement, the incidence of mortality was reduced to 11%.
The hybrid approach avoids a left thoracotomy by using
a stent graft as an alternative to an open distal anastomosis.
Although the incidence of mortality for patients undergoing
open distal/descending repair (excluding thoracoabdominal
aneurysm repair) was only 3% (1/38) at the Hospital of
the University of Pennsylvania, these patients were 18 years
younger on average than patients undergoing hybrid proce-
dures (53.0 vs 71.3 years) (P< .001). The incidence of pul-
monary complications in patients undergoing descending
aneurysm repair has been reported as up to 28%.16-18 Of
open distal cases at the Hospital of the University of
Pennsylvania, 11% required lung decortication. This is
especially important because 67% (18/27) of the hybrid
cohort compared with 51% (23/45) of the open total arch
cohort (P ¼ .077) had a significant smoking history. For
the hybrid arch population, 44% (12/27) had moderate-to-
severe chronic obstructive pulmonary disease (COPD) com-
pared with 11% (5/45) of the open arch group (P ¼ .003).
Preoperative renal failure has been reported as a predictor
of mortality in aortic arch replacement.11 In our series,
chronic renal failure was present preoperatively in 12% of
the open hybrid cohort compared with 4% of the open total
arch cohort (P ¼ .344). Although the majority of our hybrid
procedures were performed on CPB (25/27), the hybrid pro-
cedure avoided DHCA, including potential renal ischemia in
63% of patients. Overall postoperative renal failure was
similar in both cohorts (Table 3).
To determine an algorithmic approach for patient selec-
tion for either hybrid or open arch repair, criteria must beery c September 2010
FIGURE 2. Kaplan–Meier survival plot, all causes of death. P value be-
tween groups is .32 (log rank).
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smoking history, moderate-to-severe COPD, saccular aneu-
rysm with significant atherosclerotic burden, and high-grade
or mobile atheroma. As older populations with additional
comorbidities present with aortic pathologies, innovative
methods of treatment must be developed to achieve accept-
able outcomes.
In addition to age and preoperative comorbidities, patient
selection for operations on the aortic arch must parallel the
pathophysiology of the aorta. Reports have shown athero-
sclerotic pathology is a predictor of perioperative stroke.4,25
In our series, patients selected for hybrid procedure
were older by 10 years (P ¼ .008) and 93% had an
atherosclerotic aortic pathology with an extensive aortic
arch and brachiocephalic atherosclerotic burden, compared
with only 45% of patients with atherosclerotic aneurysms
in those undergoing open total arch (P< .001). Delineation
of atherosclerotic aneurysms in patients undergoing hybrid
procedures revealed that 63% (17/27) were saccular arch
aneurysms compared with 18% (8/45) in patients
undergoing open total arch procedures (P< .001). Of the
fusiform aneurysms in patients undergoing hybrid
procedures, 88% (8/9) were mega-aorta compared with
28% (5/18) in patients undergoing open total arch proce-
dures. Previously, these patients were considered prohibi-
tively high risk for conventional open arch repair because
of the associated high stroke risk. Recent series of total
arch repair for large atherosclerotic arch aneurysms still
report in-hospital mortality ranging from 6.3% to 20% and
incidence of stroke up to 12%.1,3,4,6,25 In our series,
delineation of atherosclerotic burden revealed 48.1% (13/
27) of the hybrid arch cohort had high-grade or mobile ather-
oma compared with 6.7% (3/45) of the open arch cohort
(P<.001).25 On the basis of this high atherosclerotic burden,
we perform end-to-end arch vessel anastomosis to ensureThe Journal of Thoracic and Caremoval of proximal atherosclerotic disease and decrease
the risk of embolic stroke. In our series, the overall incidence
of permanent cerebral neurologic deficit was 4% in patients
undergoing hybrid arch procedures and 9% for patients un-
dergoing open total arch procedures (P ¼ .644). Stratified
by age, the incidence of permanent cerebral neurologic defi-
cit for patients undergoing hybrid arch procedures was 4%
(1/14) for those aged less than 75 years and 0% for those
aged more than 75 years. For patients undergoing open total
arch procedures, the incidence of permanent cerebral neuro-
logic deficit was 8.8% (3/34) for those aged less than 75
years and 9.1% (1/11) for those aged more than 75 years.
The results of our series and others suggest that age is
a univariate predictor of mortality.5,22 Recent studies on
open ascending and aortic arch repairs have revealed that
mortality is 7.4% for patients aged more than 75 years and
13.5% for patients aged more than 80 years, with a stroke
incidence of 3.7% and 8%, respectively.23,24 However,
none of these patients underwent an open total arch repair.
In our series, for patients aged more than 75 years, in-
hospital mortality for hybrid arch cases was 8.3% (1/12)
and 36% (4/11) in open total arch repair cases (P ¼ .049).
Patient selection indications for open total aortic arch pro-
cedures include our exclusion criteria for hybrid arch recon-
struction, that is, younger patients, patients with infection,
and patients with collagen vascular disease, such as Marfan
syndrome. For patients undergoing open total arch repair,
there was a tendency toward multiple complex concomitant
cardiac procedures.
In developing algorithmic selection criteria for patients
who would benefit from hybrid procedures, our criteria are
based on age, aortic pathology, and comorbidities. These in-
clude aneurysms proven by M2S as saccular or mega-aorta
with significant atherosclerotic burden and transesophageal
echocardiogram evidence of high-grade or mobile atheroma.
These criteria also include patients with significant smoking
history and moderate-to-severe COPD who may not tolerate
a left thoracotomy or a thoracosternotomy, patients with
chronic renal failure, patients who would not tolerate an
open staged procedure because of comorbidities, and patients
with other significant preoperative neurologic compromise
(previous cerebral vascular accident or paraplegia). By using
these criteria, 71% (4 patients aged>75 years and 1 patient
aged<75 years) of the patients who died in the open aortic
arch cohort would now be treated at the Hospital of the Uni-
versity of Pennsylvania with the hybrid operative technique.
CONCLUSIONS
Analysis of overall mortality and morbidity of both hybrid
and open total arch procedures demonstrates similar out-
comes at the Hospital of the University of Pennsylvania.
For patients with multiple comorbidities, including ad-
vanced age, large atherosclerotic burden, and end-organ
compromise, the hybrid procedure allows for exclusion ofrdiovascular Surgery c Volume 140, Number 3 595
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function with outcomes comparable to the open procedure.
Our results indicate that hybrid arch procedures have their
primary benefit in high-risk cases, especially elderly pa-
tients aged more than 75 years with complex aortic arch pa-
thology, such as large saccular aneurysms or mega-aorta,
who were previously considered prohibitively high risk
for conventional open total arch repair. Hybrid arch proce-
dures provide a safe alternative to open repair and extend
the indication of the approach to this high-risk cohort with
midterm survival outcomes similar to those for the open to-
tal arch procedure. For younger patients with fewer comor-
bid risk factors and with exclusion criteria to hybrid arch
repair, the open total arch procedure remains a reasonable
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Dr Yutaka Okita (Kobe, Japan). I have no disclosures. Drs
Milewski and Bavaria’s group are to be congratulated on reporting
a systematic approach to aortic arch pathologies. They compared
27 patients who underwent elective open hybrid arch procedures
and 45 patients who underwent elective open total arch replacement
at the University of Pennsylvania. Although patients’ backgrounds
were not similar and the number of patients was small, they
concluded the hybrid arch procedures provided better outcome in
elderly patients.
In 1996, Kato introduced an open hybrid stent-graft approach to
the aortic arch aneurysm, and he also applied the off-pump
debranching endograft method in 1999. According to the annual
survey performed by the Japanese Association for Thoracic Sur-
gery, from 2005 to 2007, 11,000 elective arch procedures were per-
formed in Japan. A total of 5700 patients (51%) had total arch
replacement with a hospital mortality of 7.1%, and 465 patients
(4%) had hybrid stent-grafting with a hospital mortality of 6.9%.
So both procedures, open total arch replacement or hybrid proce-
dures, had similar results regarding hospital mortality in Japan.
Our own results in surgical open repair of the aortic arch in Kobe
University are as follows. FromMarch 2002 to December 2008, we
performed 231 total arch replacements using ACP at a tympanic
temperature of 25C. There were 166 elective cases, including
44 chronic aortic dissections. The mean age was 70 years. We
found 6 hospital deaths (3.6%) and 9 new strokes (5.4%). For 88
patients aged more than 75 years (53% of our patients), hospital
mortality was 4.5% (4) and stroke incidence was 5.7% (5). So by
using sophisticated techniques of brain protection and sealed
branch grafts, clinical outcome was similar, even in elderly pa-
tients. I have several questions for Dr Milewski.
In the hybrid cases, you do not need longer periods of circulatory
arrest time under deep hypothermia; however, I found a relatively
higher incidence of postoperative paraplegia or paraparesis. Whatery c September 2010
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Dwere the causes of these complications and how do you prevent
them?
Dr Milewski. There were 2 cases of postoperative paraplegia in
our hybrid group. The first case had normal deployment of the an-
tegrade graft. The second case occurred in a patient who had under-
gone an abdominal aortic aneurysm replacement and had
a pavement of the stent-graft for mega-aorta all the way down to
the celiac access, which has been shown to be high risk for paraple-
gia or spinal cord ischemia. Both of these cases occurred early in
our series, before June of 2006. Since that time, we haven’t had
any. Part of this could be anatomy alone, and obviously part of it
is the learning curve, not only in the actual deployment but also
in the learning curve in patient selection.
Dr Okita. Patients with mega-aorta syndrome would have most
of the benefits from the University Penn type III procedures.We did
extended replacement from the ascending aorta, arch, and descend-
ing aorta via a left thoracotomy in 22 patients with 1 hospital mor-
tality, but this is a big operation. You have done 8 type III
procedures, and I would like to know the mortality and morbidity
in this specific patient group.
Dr Milewski. Of those patients, there were only 2 mortalities,
and both of those patients died of multiorgan system failure.
Dr Okita. During follow-up, how many deaths did you see in
the hybrid group? By looking at the Kaplan–Meier curve, although
statistically insignificant, all deaths seem to occur within 1 year af-
ter surgery in the hybrid group. What was the cause of death, and
are there any aorta-related events?
DrMilewski.We are actually updating our data bank so that we
have a more sophisticated ability to know the exact cause of death
of the patients. We recently had a patient who was sent home to an
intermediate care facility and had a tracheostomy at that point. She
died in the outside facility. But at this point I cannot tell you specif-The Journal of Thoracic and Caically what each one of these patients died of; however, I can tell
you that we are working on that data bank to update it.
Dr Okita. Okay. The final question is regarding indications for
a hybrid procedure. In the text you gave me before, you stated that
indications of total arch replacement are younger patients, collagen
tissue disease (including Marfan), patients who require multiple
concomitant cardiac procedures, and infection. What about indica-
tions for the hybrid procedure?
DrMilewski.At this point that is basically what this study at the
University of Pennsylvania is all about, to determine exactly what
criteria to use, and it is more or less criteria building in progress.We
have only been doing the procedure since 2005, and we do not at
this point have definitive criteria for our patients, but we hope
this study and its continuance will provide the criteria.
Dr Joseph Bavaria (Philadelphia, Pa). Because I am the one
who selects the patients, I will answer that with a bit more detail.
When we chose the control group, it was a combination of proximal
descending aortic aneurysm repair and arch repair. The hybrid arch
operation is not an operation for a standard issue proximal thoracic
aortic disease process. So the selection process is basically some-
one who would require a very deep median sternotomy or a clam-
shell or something of that nature. So the selection consists of
a significant arch, even a distal arch operation. That is the whole
concept behind this procedure, really, that is, how to select cases.
In 2005 the Gore graft became available, so we decided to try the
hybrid arch procedure to see if it would work in these particular
high-risk patients who would have had an open operation before,
although high risk. We performed the operation in 27 patients.
We have the data: My plan is that we are going to basically perform
a standard operation in young patients and a hybrid operation in
older patients, as long as they have the appropriate anatomy for
this procedure.rdiovascular Surgery c Volume 140, Number 3 597
